Investor Update Reminder: Invitation to the Roche Diagnostics Investor Day 2021: Innovating diagnostics, shaping healthcare, changing lives



We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 23 March 2021 highlighting future growth drivers of the Division.
We will welcome you to the event in our new virtual 360° platform which will be accessible one day prior to the event (as of 15:00 CET). We would like to invite you to visit our virtual marketplace and participate in a self-guided virtual showroom tour. Stay tuned!

14:00-16:00 CET / 13:00-15:00 GMT
9:00-11:00am EDT / 6:00-8:00am PDT

The event will address the following topics:

  • Diagnostics market opportunities, strategy and organisation
  • Overview on R&D and new technologies
  • Late stage pipeline: Systems and diagnostics solutions for selected disease areas such as infectious diseases, cardiology and oncology

Speakers will include:

  • Thomas Schinecker, CEO Roche Diagnostics
  • Ann Costello, Global Head Roche Diagnostics Solutions
  • Palani Kumaresan, Global Head of Research & Development
  • Benjamin Lilienfeld, Life Cycle Leader Serum Work Area Systems
  • Michael Hombach, Global Clinical Leader Infectious Diseases
  • Andre Ziegler, Global Clinical Leader Cardiology
  • Jill German, Global Head of Pathology Lab

The webinar will start with presentations, followed by a Q&A session (live access to the speakers).

If you want to benefit from the entire platform (e.g. visit of virtual showroom) please register here by today, 15 March 2021.

A replay of the event will be available via >ir.roche.com

*privacy notice

Best regards,

Karl Mahler Birgit Masjost
Head of Investor Relations and Investor Relations Officer
Roche Group Planning

Roche Investor Relations
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com
Investor Relations North America
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com

Attachments

  • Original document
  • Permalink

Disclaimer

Roche Holding AG published this content on 15 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 March 2021 09:04:04 UTC.